FDA Inspection 1302280 — Cindy A. Leissinger, M.D.
The FDA completed an inspection of Cindy A. Leissinger, M.D. on February 5, 2026 in New Orleans, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 5, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- New Orleans, LA (United States)
Additional Details
Clinical Investigator (CI)